(Q48368636)

11 February 2018

title

Is mifepristone useful in psychotic depression? (English)

1 reference

11 February 2018

1 reference

1 reference

Bernard J Carroll

1

1 reference

11 February 2018

Robert T Rubin

series ordinal

2

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 December 2006

1 reference

11 February 2018

published in

Neuropsychopharmacology

1 reference

11 February 2018

volume

31

1 reference

11 February 2018

issue

12

1 reference

11 February 2018

page(s)

2793-4; author reply 2795-7

1 reference

11 February 2018

An open label trial of C-1073 (mifepristone) for psychotic major depression

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301170

Clinical and biological effects of mifepristone treatment for psychotic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301170

The choice of antipsychotic drugs for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301170

An assessment of clinically useful measures of the consequences of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301170

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301170

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301170

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.NPP.1301170

1 reference

11 February 2018

Dimensions Publication ID

1021345202

0 references

1 reference

11 February 2018